Signals
Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
A new ACC expert analysis sets out a practical approach to antihypertensive medication use in pregnancy and lactation, naming extended-release nifedipine and labetalol as preferred options in pregnancy, and nifedipine, amlodipine, enalapril and labetalol as preferred options during lactation. The clinical message is clear. The policy message is bigger: pregnant and postpartum patients need safe…
Metabolic health is no longer just a clinic problem. It is a city, climate and equity problem
Can AstraZeneca challenge the obesity market leaders? New GLP-1 data signal growing ambitions beyond oncology
AMR Stewardship Starts Before the Antibiotic Is Prescribed
HEARTS 2.0: Latin America moves beyond hypertension and into cardio-kidney-metabolic care
GIST Care Looks Beyond First-Generation KIT Control
World Cup Health Guidance Turns Football Into a Public-Health Test
Not All Eye Infections Are Equal: New Evidence Points to a Precision Medicine Approach
What happens when surgeons no longer need to be in the same country as their patients?
EMA backs first oral obesity GLP-1 as pills push treatment towards mass-market adoption
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.